Abstract:Background/Aims: Hepatic artery stenosis ( HAS) is a potentially life-threatening complication of liver transplantation because the associated mortality and morbidity rates are high. Surgical reconstruction was recommended as first choice of treatment and interventional radiologic techniques have been introduced recently. However, the mid-or long-term outcomes of HAS were unclear. The purpose of this study was to evaluate the efficacy of interventional therapy and clinical outcomes of HAS following liver transplantation. Methods: A retrospective analysis was performed for 20 cases of HAS documented by angiography from October 2003 to August 2007 at the authors' institution. All patients underwent transluminal interventional therapy including percutaneous transluminal angioplasty and endovascular stent placement. The technical results, hepatic artery patency and clinical outcome were reviewed. Results: All patients were treated with interventional management. Technical and immediate success was 100%. Of 8 patients with early HAS ( within 1 month of transplantation), 1 underwent retransplantation due to deterioration of liver function. One died of acute liver failure waiting for retransplantation. Of 12 patients with late HAS (after 1 month of liver transplantation), 1 died of severe sepsis 38 days after transplantation. Five patients underwent late retransplantation due to ischemic-type biliary strictures or recurrent attacks of cholangitis. One of these patients died 11 days after retransplantation. The median follow-up of all 20 patients was 14.4 months after liver transplantation. The Kaplan-Meier curve of patency showed that cumulated primary patency of hepatic artery interventional treatment at 3, 6 and 12 months was 94, 87 and 79%, respectively. Two patients died of causes unrelated to HAS. Three patients developed recurrent HAS and were successfully treated with second interventional therapy. Eight patients (40%) developed ischemic-type biliary strictures and 7 underwent endoscopic treatment or percutaneous transhepatic cholangiodrainage. Graft function in 5 patients improved. The Kaplan-Meier curve of survival showed that the 1-and 2-year cumulated survival rates of early and late HAS were 87.5 and 43.8% and 81.5 and 61.1%, respectively. There was no significant difference in 1-and 2-year survival rates between early and late HAS (log-rank test, p = 0.928). Conclusion: Interventional therapy is an effective treatment for both early and late HAS with excellent short- and mid-term outcomes, while without irreversible graft dysfunction resulted from HAS. However, the patients have a high incidence of schemic-type biliary lesions. Copyright (c) 2008 S. Karger AG, Basel

[Percutaneous transhepatic metallic stent placement for the treatment of post-transplantation portal vein stenosis]

Interventional Management of Portal Vein Stenosis after Liver Transplant: Single Center Experience.

Treatment Options for Portal Hypertension in the Era of Liver Transplantation

Long-term results of vascular stent placements for portal vein stenosis following liver transplantation

Computational Fluid Dynamics-Based Blood Flow Assessment Facilitates Optimal Management of Portal Vein Stenosis After Liver Transplantation

Analysis of three-dimensional visualization of severe portal vein stenosis after liver transplantation and clinical efficacy of portal vein stent implantation

Stent Placement in Treating Hepatic Artery Stenosis after Liver Transplantation

Clinical analysis of 18 patients with portal vein stenosis after liver transplantation

Portal vein stent placement after hepatobiliary and pancreatic surgery

Endovascular Treatment of Acute Posttransplant Portal Vein Thrombosis Due to Portal Steal From Mesocaval And Coronary Portosystemic Shunts

Treatment of Hepatic Venous Outflow Stenosis after Living Donor Liver Transplantation by Insertion of an Expandable Metallic Stent.

Endovascular interventional therapy of portal vein stenosis after pediatric liver transplantation

Metallic Stents for Hepatic Venous Outflow Obstruction After Living-Donor Liver and Their Therapeutic Effects

Endovascular treatment of portal vein stenosis after pediatric liver transplantation for biliary atresia

Portal Venous Stent Placement for Treatment of Portal Hypertension Caused by Benign Main Portal Vein Stenosis

MANAGEMENT OF PORTAL VEIN THROMBOSIS IN PATIENTS WITH CIRRHOSIS IN THE LIVER TRANSPLANTATION

Single-Center Experience of Therapeutic Management of Hepatic Artery Stenosis after Orthotopic Liver Transplantation

Safety and effectiveness of renoportal bypass in patients with complete portal vein thrombosis: An analysis of 10 patients

Reno-portal shunt for liver transplant, an alternative inflow for recipients with grade III-IV portal vein thrombosis: Tips for a better outcome

Abstract No. 206: Long-Term Outcomes of Hepatic Artery Stenting for Patients with Hepatic Artery Stenosis after Liver Transplantation

Percutaneous transluminal angioplasty of hepatic artery stenosis in patients after orthotopic liver transplantation: mid-term results